Evidence map›Paper›PMID 35799038›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2023

Ongoing vascular inflammation evaluated by

Kenji Suda, Nobuhiro Tahara, Munehisa Bekki, Tomohisa Nakamura, Akihiro Honda, Shintaro Kishimoto, Yoshiyuki Kagiyama, Motofumi Iemura, Kiminori Fujimoto, Toshi Abe and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Embers after fire: Are we close to real time visualization of persistent inflammation post-Kawasaki disease?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Kenji SudaDepartment of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan. suda_kenji@med.kurume-u.ac.jp.
Nobuhiro TaharaCardiovascular Research Institute, Kurume University School of Medicine, Kurume, Japan. ntahara@med.kurume-u.ac.jp.
Munehisa BekkiDivision of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Tomohisa NakamuraDivision of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Akihiro HondaDivision of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Shintaro KishimotoDepartment of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.
Yoshiyuki KagiyamaDepartment of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.
Motofumi IemuraDepartment of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.
Kiminori FujimotoDepartment of Radiology, Kurume University School of Medicine, Kurume, Japan.
Toshi AbeDepartment of Radiology, Kurume University School of Medicine, Kurume, Japan.
Yoshihiro FukumotoCardiovascular Research Institute, Kurume University School of Medicine, Kurume, Japan.
Kurume University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to determine whether ongoing vascular inflammation presents in patients who had coronary artery aneurysms (CAAs) caused by Kawasaki disease (KD).

methodsSubjects were 26 patients with a history of KD; 15 had giant CAA (gCAA) ≥ 8.0 mm and 11 had smaller CAA (smCAA) < 8 mm in the acute phase. They underwent X-ray computed tomography and

resultsCaTBR and TaTBR were significantly higher in gCAA than in smCAA (P < .005 for both values) and were significantly higher even in patients without any metabolic risk factor (P < .05 for both values). The CAA size in acute phase significantly positively correlated with CaTBR (R

conclusionsOngoing vascular inflammation may present long after KD, especially in patients with severe inflammation expressed as gCAA in the acute phase.

Indexed as

Fluorodeoxyglucose F18Mucocutaneous Lymph Node SyndromeHumansInflammationPositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18RadiopharmaceuticalsCADinflammationothersPET

Identifiers

PMID35799038
OpenAlexW4284880819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.